Dr. Mehiar O. El-Hamdani, MD

Dr. El-Hamdani practices at Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network.

Dr. El-Hamdani's NPI, 1932290939, was assigned on September 27, 2006. Dr. El-Hamdani holds West Virginia license 19829.

Dr. El-Hamdani's primary practice is Cabell Huntington Hospital, at 1340 Hal Greer Boulevard, Huntington, WV 25701 in Cabell County. The practice phone is (304) 526-2000.

Dr. El-Hamdani's primary practice is Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network. Dr. El-Hamdani is also affiliated with St. Mary's Medical Center. The medical group on file is Marshall Health. Dmand AI also links Dr. El-Hamdani to 1 more hospital, 5 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Hamdani practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. El-Hamdani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. El-Hamdani is licensed in West Virginia.

CMS data shows 1,263 Medicare services from Dr. El-Hamdani across 15 procedure codes in 2024, for 591 Medicare patients. Medicare paid $96,122 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 591 Medicare patients who saw Dr. El-Hamdani in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Hamdani's median patient age at 72, with 48% women.

In 2024, Dr. El-Hamdani wrote 2,709 Medicare Part D claims for 517 patients. 90% of them were for generic drugs. CMS names the drug for 2,494 of them, across 34 drugs with 11 or more claims each, at $272,471 in total drug cost. In 2023, CMS named 2,650 claims across 36 drugs.

Dr. El-Hamdani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of coronary angioplasty and stenting by Dr. El-Hamdani, more than 83% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. El-Hamdani, published from 2017 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Atherosclerosis, Diet, Western and Fatty Liver. Dr. El-Hamdani has published most often in Arch Med Sci Atheroscler Dis. Dr. El-Hamdani's most frequent co-authors are Muchi Ditah Chobufo, MD, Preeya Tushar Shah, MD and Krithika Srikanthan, MD.

Dmand AI links Dr. El-Hamdani to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 173 general payments to Dr. El-Hamdani from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Cook Medical LLC paid the most, $1,859.